Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
DNMT inhibitor
DRUG CLASS:
DNMT inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
azacitidine (75)
decitabine (40)
decitabine/cedazuridine (10)
azacitidine oral (7)
NTX-301 (1)
OR-2100 (0)
ASTX030 (0)
SGI-110 (0)
azacitidine (75)
decitabine (40)
decitabine/cedazuridine (10)
azacitidine oral (7)
NTX-301 (1)
OR-2100 (0)
ASTX030 (0)
SGI-110 (0)
›
Associations
(133)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
azacitidine oral
Sensitive: A1 - Approval
azacitidine oral
Sensitive
:
A1
azacitidine oral
Sensitive: A1 - Approval
azacitidine oral
Sensitive
:
A1
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
decitabine
Sensitive: A1 - Approval
decitabine
Sensitive
:
A1
decitabine
Sensitive: A1 - Approval
decitabine
Sensitive
:
A1
No biomarker
Myelodysplastic Syndrome
No biomarker
Myelodysplastic Syndrome
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
No biomarker
Chronic Myelomonocytic Leukemia
No biomarker
Chronic Myelomonocytic Leukemia
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
No biomarker
Myelodysplastic Syndrome
No biomarker
Myelodysplastic Syndrome
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
No biomarker
Myelodysplastic Syndrome
No biomarker
Myelodysplastic Syndrome
decitabine
Sensitive: A1 - Approval
decitabine
Sensitive
:
A1
decitabine
Sensitive: A1 - Approval
decitabine
Sensitive
:
A1
No biomarker
Chronic Myelomonocytic Leukemia
No biomarker
Chronic Myelomonocytic Leukemia
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
No biomarker
Juvenile Myelomonocytic Leukemia
No biomarker
Juvenile Myelomonocytic Leukemia
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
decitabine/cedazuridine
Sensitive: A1 - Approval
decitabine / cedazuridine
Sensitive
:
A1
DNMT3A mutation
Acute Myelogenous Leukemia
DNMT3A mutation
Acute Myelogenous Leukemia
azacitidine
Sensitive: B - Late Trials
azacitidine
Sensitive
:
B
azacitidine
Sensitive: B - Late Trials
azacitidine
Sensitive
:
B
NPM1 mutation
Acute Myelogenous Leukemia
NPM1 mutation
Acute Myelogenous Leukemia
azacitidine
Sensitive: B - Late Trials
azacitidine
Sensitive
:
B
azacitidine
Sensitive: B - Late Trials
azacitidine
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.